Abstract:BACKGROUND AND AIM OF THE STUDY Calcific aortic valve disease (CAVD) is a commonly acquired valvular disease. Although previous studies have shown valve calcification to be mediated by a chronic inflammatory disease process, with many similarities to atherosclerosis that included inflammatory cell infiltrates, lipoproteins, lipids, extracellular bone-matrix proteins, and bone minerals, little is known of the mechanisms of the cellular and molecular components and processes. It has recently been hypothesized that the calcific aortic valve is a product of active inflammation, similar to the atherosclerosis pathological process. Thus, the cessation of statin therapy should, in theory, have an effect on the treatment of CAVD and on aortic valve myofibroblasts (AVMFs), which play an important role in aortic valvular calcification. The study aim was to determine if oxidized low-density lipoprotein (oxLDL) could stimulate the apoptosis of AVMFs and the calcific-related pathway, and whether atorvastatin could inhibit the effects of AVMFs induced by oxLDL. The Wnt/GSK-3β/β-catenin signaling pathway may play a key role in this process, thereby making a major contribution to aortic valve calcification. METHODS AVMFs were successfully acquired using a combination of trypsin and collagenase enzyme digestion, and made phenotypic for the identification for alpha-smooth muscle actin (α-SMA). Cell apoptosis was monitored using flow cytometry, bone protein expression by Western blot, and related gene expression by reverse transcription polymerase chain reaction (RT-PCR). RESULTS A positive identification of α-SMA, a myofibroblast marker, confirmed the successful harvesting of myofibroblasts. OxLDL significantly induced cell apoptosis (p < 0.05), and this became even more obvious after 48 h (p < 0.01). OxLDL also significantly increased the protein expression of all differentiation markers (p < 0.05), as confirmed through Western blotting and RT-PCR, while atorvastatin significantly reduced the effects of oxLDL (p < 0.05). CONCLUSION Among the mechanisms of the cellular and molecular components and processes, oxLDL increased the valve calcification-related signaling pathway by increasing extracellular bone-matrix protein that produces osteoblastic gene markers via the Wnt/GSK-3β/β-catenin pathway. And atorvastatin also prevented any oxLDL-induced effects through the same pathway, this may represent a new therapeutic target for CAVD, as an alternative to traditional valve replacement surgery.

Oxidized HDL, As a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells

Association Between Plasma Lipoprotein Levels and Aortic Valve Calcification among Patients with Aortic Valve Replacement Surgery: A Retrospective Study

Identification of Key Genes in Calcific Aortic Valve Disease by Integrated Bioinformatics Analysis.

Histone Deacetylase 6 Reduction Promotes Aortic Valve Calcification Via an Endoplasmic Reticulum Stress-Mediated Osteogenic Pathway.

The Effect of Oxldl on Aortic Valve Calcification Via the Wnt/ Β-Catenin Signaling Pathway: an Important Molecular Mechanism.

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Oxidative stress and valvular endothelial cells in aortic valve calcification

Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis

Deficiency of CCAAT/enhancer-binding Protein Homologous Protein (CHOP) Prevents Diet-Induced Aortic Valve Calcification in Vivo

Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease

Decreased Glucagon-Like Peptide-1 Is Associated With Calcific Aortic Valve Disease: GLP-1 Suppresses the Calcification of Aortic Valve Interstitial Cells

Hypercholesterolemia Accelerates Vascular Calcification Induced by Excessive Vitamin D Via Oxidative Stress

Knockdown of Estrogen‐related Receptor Α Inhibits Valve Interstitial Cell Calcification in Vitro by Regulating Heme Oxygenase 1

Decreased Serum HMGB1 Associated with M2 Macrophage Polarization and Patients with Calcific Aortic Valve Disease

The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease

Aortic calcification accelerates cardiac dysfunction via inducing apoptosis of cardiomyocytes

Integrative Multi-Omics Analysis in Calcific Aortic Valve Disease Reveals a Link to the Formation of Amyloid-Like Deposits

Antibody Microarray Analysis of Serum Inflammatory Cytokines in Patients with Calcific Aortic Valve Disease

Serum HDL-C subfractions as predictors of cardiovascular calcification in hemodialysis patients: novel insights and clinical implications

Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2

Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis